Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Inhye Ahn, M.D.

Concepts (141)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Lymphocytic, Chronic, B-Cell35202416266.650 Why?
Adenine1820249772.990 Why?
Piperidines18202416452.450 Why?
Pyrazoles12202119842.150 Why?
Pyrimidines13202329791.710 Why?
Protein Kinase Inhibitors14202355941.050 Why?
Vidarabine220243281.000 Why?
Antineoplastic Agents122024135500.920 Why?
Tumor Suppressor Protein p533202128960.810 Why?
Lymphoma, B-Cell220229290.640 Why?
Pneumocystis carinii12016720.520 Why?
Pneumonia, Pneumocystis120162450.490 Why?
Antineoplastic Combined Chemotherapy Protocols72023115870.480 Why?
Antibodies, Bispecific320231850.480 Why?
Philadelphia Chromosome120131150.430 Why?
Safety1201711460.430 Why?
Drug Resistance, Neoplasm6202451640.420 Why?
Irritable Bowel Syndrome120174510.400 Why?
Herpes Zoster Vaccine22022490.370 Why?
Integrin alpha4beta1220231180.370 Why?
Multiple Myeloma3201651100.330 Why?
Warfarin1201715060.330 Why?
Cyclophosphamide2202421940.300 Why?
Apoptosis1202494290.300 Why?
Myeloproliferative Disorders120136180.280 Why?
Benzamides3202113640.280 Why?
Phospholipase C gamma220171250.280 Why?
Pyrazines3202111920.280 Why?
Follow-Up Studies72024390770.230 Why?
Lymphoma2202318870.230 Why?
Renal Insufficiency, Chronic1201722420.220 Why?
Tumor Microenvironment2202337550.220 Why?
Disease-Free Survival3202067800.210 Why?
Aged, 80 and over102021582990.210 Why?
Humans4320247524110.200 Why?
Aged1820211665850.200 Why?
Vaccines, Synthetic220226140.190 Why?
Treatment Outcome102024642500.190 Why?
Molecular Targeted Therapy2202427820.190 Why?
Proto-Oncogene Proteins c-bcl-22202413910.180 Why?
Leukemia, Hairy Cell12020830.180 Why?
Hepatitis B Vaccines120211830.170 Why?
Hypertension1201984980.170 Why?
Herpes Zoster120222470.170 Why?
Lymphoma, Follicular120234500.170 Why?
Antigens, CD19220214120.170 Why?
Atrial Fibrillation1201751480.160 Why?
Smith-Magenis Syndrome12017190.150 Why?
Immunotherapy3202346010.150 Why?
Cell Transformation, Neoplastic2201828220.150 Why?
Protein-Tyrosine Kinases2201724100.150 Why?
Prognosis52023293370.140 Why?
Disease Progression32020134050.140 Why?
Chromosomes, Human, Pair 17120174210.130 Why?
Male1820213549080.130 Why?
Immunity120219930.120 Why?
Sulfonamides1202419630.120 Why?
Middle Aged1420212170390.110 Why?
Mutation42023297060.110 Why?
Chromosome Deletion1201713870.110 Why?
Neoplasm, Residual120189940.110 Why?
Switzerland220233160.100 Why?
Thrombocythemia, Essential120131070.100 Why?
Survival Rate32021127450.100 Why?
Hydroxyurea120132830.100 Why?
Antiviral Agents2202130310.100 Why?
Polycythemia Vera120131580.100 Why?
Female1420213860850.100 Why?
Transplantation, Autologous1201621090.100 Why?
Histone-Lysine N-Methyltransferase120166800.100 Why?
Salvage Therapy1201812650.100 Why?
Survival Analysis22020101720.090 Why?
Adult920212169270.090 Why?
Hodgkin Disease1201813770.090 Why?
Kaplan-Meier Estimate2201865010.090 Why?
Congresses as Topic220237950.080 Why?
Neoplasm Proteins1202035990.080 Why?
Receptors, Antigen, B-Cell220235450.070 Why?
Bone Marrow1201829020.070 Why?
CD8-Positive T-Lymphocytes1202144950.070 Why?
Quinazolines1201313550.070 Why?
Anemia1201614950.070 Why?
Clinical Trials as Topic1202179960.060 Why?
Repressor Proteins1201629730.060 Why?
High-Throughput Nucleotide Sequencing1201736000.060 Why?
Evidence-Based Medicine1201636780.060 Why?
Autoimmune Diseases1201622140.060 Why?
Neoplasm Staging12018110630.050 Why?
Comorbidity12017104750.050 Why?
Coronavirus Infections1202030680.050 Why?
Pneumonia, Viral1202031870.050 Why?
Cladribine12020360.050 Why?
Enzyme Induction120204540.040 Why?
Thrombosis1201330180.040 Why?
Hematopoietic Stem Cell Transplantation1201655510.040 Why?
Immunization, Passive120206100.040 Why?
Signal Transduction12021232340.040 Why?
Incidence12016211570.040 Why?
Single-Chain Antibodies120181070.040 Why?
RNA, Neoplasm120207500.040 Why?
Lymphocytosis120181200.040 Why?
Leukocytes, Mononuclear1202318200.030 Why?
Hematologic Diseases120204940.030 Why?
Immunity, Humoral120205940.030 Why?
Adjuvants, Immunologic1202110240.030 Why?
Animals320231668110.030 Why?
Mice, Inbred NOD1201818090.030 Why?
Mice, SCID1201826170.030 Why?
Immunoglobulin M1201815190.030 Why?
Headache1202012350.030 Why?
Drug Administration Schedule1202048760.030 Why?
Drug Therapy, Combination1202164790.020 Why?
Cell Adhesion1201830880.020 Why?
Disease Management1202124800.020 Why?
Anti-Inflammatory Agents1202017930.020 Why?
Tumor Cells, Cultured1201861370.020 Why?
Retrospective Studies22021791330.020 Why?
Xenograft Model Antitumor Assays1201835540.020 Why?
In Situ Hybridization, Fluorescence1201624950.020 Why?
Vaccination1202133220.020 Why?
Phosphatidylinositol 3-Kinases1201828680.020 Why?
Epigenesis, Genetic1202137060.020 Why?
Polymerase Chain Reaction1201760580.020 Why?
Antibodies, Monoclonal1202391010.020 Why?
Biopsy1201867430.020 Why?
Lymph Nodes1201834740.020 Why?
Cells, Cultured12021189150.020 Why?
Neoplasm Recurrence, Local1202392070.020 Why?
RNA, Messenger12020127390.020 Why?
Pain1202049890.020 Why?
Multivariate Analysis12018121380.010 Why?
T-Lymphocytes12021100350.010 Why?
Mice22023805500.010 Why?
Combined Modality Therapy1201685390.010 Why?
Proportional Hazards Models12018124550.010 Why?
DNA1201772150.010 Why?
Sensitivity and Specificity12017145880.010 Why?
Pandemics1202085110.010 Why?
Gene Expression Profiling1201693560.010 Why?
United States12021714380.010 Why?
Young Adult12016576320.010 Why?
Ahn's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (141)
Explore
_
Co-Authors (26)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.